LEADER 02294nam 2200409 n 450 001 996385735703316 005 20200818214305.0 035 $a(CKB)4940000000071480 035 $a(EEBO)2240918300 035 $a(UnM)ocm99890741e 035 $a(UnM)99890741 035 $a(EXLCZ)994940000000071480 100 $a19860604d1646 uy 101 0 $aeng 135 $aurbn||||a|bb| 200 12$aA iustification of two points now in controversie with the Anabaptists concerning baptisme$b[electronic resource] $ethe first is, that infants of Christians ought to be baptized, with grounds to prove it, and their objections answered. With a briefe answer to Master Tombes twelve doubtfull arguments against it in his exercitation about infants baptisme. Also a briefe answer to Captaine Hobsons five arguments in his falacy of infants baptisme, being (as he saith) that which should have beene disputed by him, and Mr. Knowles, and some others, against Mr. Calamy and Mr. Cranford. The second point is, that the sprinckling the baptized more agreeth with the minde of Christ then dipping or plunging in or under the water: with grounds to prove it, and a briefe auswer [sic] to what they have to say against it. /$fBy T.B 210 $aLondon $cPrinted for Henry Shepard at the Bible in Tower-street, and for WIlliam Ley at his shop in Pauls Church-yard neere Doctors Commons$d1646 215 $a[1+] p 300 $aT.B. = Thomas Bakewell. 300 $aAnnotation on Thomason copy: "Jan: 19th 1645"; the second 6 in imprint date crossed out. 300 $aA fragment: title page only, much stained and with print show-through. 300 $aReproduction of original in the British Library. 330 $aeebo-0018 606 $aInfant baptism$vEarly works to 1800 606 $aAnabaptists$vControversial literature$vEarly works to 1800 608 $aTitle pages$zEngland$y17th cent. 615 0$aInfant baptism 615 0$aAnabaptists 700 $aBakewell$b Thomas$fb. 1618 or 19.$01003030 801 0$bCu-RivES 801 1$bCu-RivES 801 2$bCStRLIN 801 2$bCu-RivES 906 $aBOOK 912 $a996385735703316 996 $aA iustification of two points now in controversie with the Anabaptists concerning baptisme$92302632 997 $aUNISA LEADER 07973nam 2200733 450 001 9910815203403321 005 20200520144314.0 010 $a1-118-92527-0 010 $a1-119-06273-X 010 $a1-118-92528-9 035 $a(CKB)3710000000412053 035 $a(EBL)1895759 035 $a(SSID)ssj0001481262 035 $a(PQKBManifestationID)11893800 035 $a(PQKBTitleCode)TC0001481262 035 $a(PQKBWorkID)11498358 035 $a(PQKB)11075098 035 $a(DLC) 2015007609 035 $a(MiAaPQ)EBC1895759 035 $a(Au-PeEL)EBL1895759 035 $a(CaPaEBR)ebr11053046 035 $a(CaONFJC)MIL809595 035 $a(OCoLC)904012290 035 $a(PPN)240410602 035 $a(EXLCZ)993710000000412053 100 $a20150520h20152015 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe ADA practical guide to substance use disorders and safe prescribing /$fedited by Michael O'Neil 210 1$aHoboken, New Jersey :$cWiley Blackwell :$cAmerican Dental Association,$d2015. 210 4$dİ2015 215 $a1 online resource (239 p.) 225 1 $aPractical Guide Series 300 $aDescription based upon print version of record. 311 $a1-118-88601-1 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aMachine generated contents note: Contributors xxxPreface xxxAcknowledgements xxx1. Substance Use Disorders, Drug Diversion and Pain Management- The Scope of the Problem / Michael O'Neil1. Introduction2. Definitions3. Overview: SUD, Drug Misuse, Drug diversion and Pain Managementa. SUDb. Medication Misusec. Alcoholismd. Drug Diversione. Pain Management in Dentistry4. Understanding the Cultures of SUD, Drug Misuse and Drug Diversiona. Sharing Cultureb. Income Driven Culturec. Substance Abuse Cultured. Addiction Culturee. Combination of Cultures5. Summary2. Understanding the Disease of Substance Use Disorder / Carl Rollynn Sullivan and James Berry1. Introduction2. Definitions3. Epidemiology: Drug / Alcohol4. Pathophysiology5. Signs /Symptoms/ Behaviora. alcoholb. benzodiazepinesc. opioidsd. stimulantse. cannabisf. nicotineg. hallucinogens, designer drugs, inhalants6. Treatment methodsa. Behavior modification and counseling1. Motivational Interviewing2. CBT3. Contingency Management4. AA / 12 stepsb. Pharmacological management(Agents, pharmacology, pharmacokinetics, dosing, adverse effects, contraindications, drug selection, goals, duration of treatment, monitoring, outcome documentation)7. Summary3. Principles of Pain Management in Dentistry / Paul Moore and Elliot Hersh1. Introduction2. Definitions3. Neurophysiology and Neuroanatomy of Acute Inflammatory Pain4. Agents, pharmacology, pharmacokinetics, dosing, adverse effects, contraindications, Drug selection, duration of treatment, monitoring, documentationa. nonopioidb. opioid5. Medication Assisted Therapies for Drug Dependence6. Adjunctive Drugs7. Preemptive Analgesics8. Corticosteroids9. Guidelines to Analgesic Therapy10. Summary5. Special populations (renal insufficiency, coagulopathies, etc.)6. Safe prescribing considerations7. Summary4. Special Pain Management ConsiderationsMichael O'Neil1. Introduction2. Definitions3. Interviewing the Patient: Establishing Goals of Treatment4. Pharmacological Treatment of Opioid Addiction / Acute Paina. methadoneb. buprenorphinec. naltrexone5. Acute pain management patients with chronic nonmalignant pain6. Summary5. Sedation and Anxiolysis / Matthew Cooke1. Introduction2. Definitions3. Spectrum of Anesthesia and Sedation4. Preoperative evaluation5. Physical Status Classification6. Sedation7. Medications in Patients with SUDa. nitrous oxideb. benzodiazepinesc. opioidsd. ketaminee. propofolf. alpha-agonistg. local anesthetics8. Balance Anesthesia9. Monitoring and documentation10. Moderate conscious sedation11. Deep sedation12. Emergencies13. Special considerations14. Summary6. Common Substances and Medications of Abuse / George Raymond and William Maloney1. Introduction2. Definitions3. Signs and symptoms4. (drugs/chemicals, pharmacology, effects, routes, dental characteristics/patho, disease specific complications)a. Illicit drugs1. Stimulants - Methamphetamine, Cocaine2. Hallucinogens3. Opioids4. Inhalants5. CNS depressants6. Marijuana5. Prescription Drugs1. Opioids2. Stimulants3. CNS depressants4. Antipsychotics5. Muscle relaxants6. Anticonvulsants7. Other Agents6. OTCs7. Summary7. Nicotine and tobacco Cessation / Frank Vitale and Amanda Eades1. Introduction2. Definitions3. Epidemiology -cigarettes, cigars, pipes, water pipes, chewing tobacco, dip/snuff4. Oral effects of tobacco5. Dental practitioner Management of Tobacco USEa. Brief interventionb. Low intensityc. Moderate intensityd. Spit tobacco interventions6. Medication Managementa. Role of nicotineb. NRTc. Individual Agentsd. Non FDA approved treatments7. Summary8. Detection and Deterrence of Substance Use Disorder and Drug Diversion in Dental Practice / Sarah Melton and Ralph Orr1. Introduction2. Definitions3. Screening patients and referrals for treatment/interventiona. SBIRTb. CAGEc. NMASSIST4. Schemes and scamsa. In office behaviorsb. Behavior preventionc. Out of office behaviorsd. Dental practitioner Diversion5. PDMPa. Brief History of PDMPsb. PDMP as a tool / general principlesc. Interpreting PDMP reportsd. Case6. Drug disposal7. Universal Safe prescribing practices9. Summary9. Dentist Interviewing and Counseling of Patients with Substance Use Disorders and Dealing with Drug Seeking Patients / George Raymond and William Maloney1. Introduction2. Definitions3. Pre-interview considerations4. Questions to ask5. Interviewing / counseling6. Screening tools7. Documentation8. Summary10. Office Management of Controlled Substances and Record Keeping / Carlos Aquino1. Introduction2. Definitions3. Federal and State Regulations4. Common violations by dentista. Scope of practiceb. Record keepingc. Storaged. Record keeping5. Record Keepinga. Purchasing / storage /securityb. Drug disposal6. Documentation7. Surviving a Dental Board Inspection or DEA Audit8. Due Diligence9. Non-Controlled Substance Management10. Summary11. The Impaired Dental Health Professional and Office Staff / William Kane1. Introduction2. Definitions3. Epidemiology of Substance Use Disorder in healthcare4. Neurobiology5. Stigma of Addiction6. Risk Factors7. Substances of Choice8. Identification of the Impaired Professional9. Interventions10. Treatment11. Well-being Committees12. Summary12. Due Diligence and Safe Prescribing / Michael O'Neil1. Introduction2. Definitions3. Case Scenarios A-J4. SummaryContinuing Education Questions, xxxIndex xxx. 330 $a"This is in addition to a variety of legal regulations dentists must follow regarding the storage and record keeping of controlled substances"--Provided by publisher. 410 0$aPractical guide series (American Dental Association) 606 $aDental care$zUnited States 606 $aSubstance-Related Disorders$zUnited States 606 $aDental Offices$xorganization & administration$zUnited States 606 $aDentist-Paitient Relations$zUnited States 606 $aDrug Prescriptions$xstandards$zUnited States 606 $aDrug and Narcotic Control$zUnited States 615 0$aDental care 615 0$aSubstance-Related Disorders 615 0$aDental Offices$xorganization & administration 615 0$aDentist-Paitient Relations 615 0$aDrug Prescriptions$xstandards 615 0$aDrug and Narcotic Control 676 $a617.6061 702 $aO'Neil$b Michael$c(Pharmacist), 712 02$aAmerican Dental Associ0ation, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910815203403321 996 $aThe ADA practical guide to substance use disorders and safe prescribing$94086034 997 $aUNINA